TITLE

Primer on Medical Genomics Part IX: Scientific and Clinical Applications of DNA Microarrays--Multiple Myeloma as a Disease Model

AUTHOR(S)
Shaughnessy Jr., John
PUB. DATE
September 2003
SOURCE
Mayo Clinic Proceedings;Sep2003, Vol. 78 Issue 9, p1098
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Part IX. Discusses the development of DNA microarrays for the diagnosis and prognosis of multiple myeloma. Dissection of transcriptome of plasma cells; Use of molecular signatures to distinguish normal and malignant plasma cells; Gene expression changes.
ACCESSION #
10866130

 

Related Articles

  • Guidelines on the diagnosis and management of multiple myeloma treatment: Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular Project guidelines: Associação Médica Brasileira - 2012. de Moraes Hungria, Vânia Tietsche; de Queiroz Crusoe, Edvan; Quero, Adriana Alvarez; Sampaio, Manuella; Maiolino, Angelo; Bernardo, Wanderley Marques // Revista Brasileira de Hematologia e Hemoterapia;2013, Vol. 35 Issue 3, p201 

    The article discusses the parameters that shoould be used for clinical diagnosis, the evaluation of severity and standardized treatment that can be used by hematologists in the treatment of patients with multiple myeloma (MM). It mentions that MM is a disorder characterized by the abnormal...

  • Cytogenetics Helps Determine Diagnosis and Prognosis for Multiple Myeloma. Becze, Elisa // ONS Connect;Dec2012, Vol. 27 Issue 12, p18 

    The article focuses on the determination of the diagnosis and prognosis for multiple Myeloma by the use of cytogenetics. It mentions of the role of environmrnt and family history in causing genetic changes and mutations. It also focuses on Aneuploidy as a type of chromosomal mutation that result...

  • The multiple oral presentations of multiple myeloma. Cardoso, Richard C.; Gerngross, Peter J.; Hofstede, Theresa M.; Weber, Donna M.; Chambers, Mark S. // Supportive Care in Cancer;Jan2014, Vol. 22 Issue 1, p259 

    Purpose: The purpose of this case series is to show the varied oral presentations of multiple myeloma, illustrating the importance of carefully surveying the oral cavity for suspicious lesions that could be indicative of palpable disease and/or recurrence. The diagnostic criteria and prognostic...

  • Diagnostic and Prognostic Implications of Spine Magnetic Resonance Imaging at Diagnosis in Patients with Multiple Myeloma. Ik-Chan Song; Ji-Na Kim; Yoon-Seok Choi; Haewon Ryu; Myung-Won Lee; Hyo-Jin Lee; Hwan-Jung Yun; Samyong Kim; Soon Tae Kwon; Deog-Yeon Jo // Cancer Research & Treatment;2015, Vol. 47 Issue 3, p465 

    Purpose: The aim of this study is to determine the diagnostic and prognostic role of baseline spinal magnetic resonance imaging (MRI) in patients with multiple myeloma. Materials and Methods: We enrolled patients newly diagnosed with multiple myeloma from 2004-2011 at a single center. Abnormal...

  • F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders. Dammacco, Franco; Rubini, Giuseppe; Ferrari, Cristina; Vacca, Angelo; Racanelli, Vito // Clinical & Experimental Medicine;Feb2015, Vol. 15 Issue 1, p1 

    Conventional radiographic skeletal survey has been for many years the gold standard to detect the occurrence of osteolytic lesions in patients with multiple myeloma (MM). However, the introduction of more sensitive imaging procedures has resulted in an updated anatomic and functional Durie and...

  • 4. From MGUS to symptomatic MM.  // Hematology Journal;2003 Supplement, Vol. 4 Issue 1, pS121 

    The Hematology Journal (2003) 4, S121-S135. doi:10.1038/sj.thj.6200284

  • Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Kyle, R A; Rajkumar, S V // Leukemia (08876924);Apr2014, Vol. 28 Issue 4, p980 

    A correction to the article "Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma" that was published in the 2009 issue is presented.

  • Serum Level of Lactate Dehydrogenase is a Useful Clinical Marker to Monitor Progressive Multiple Myeloma Diseases: A Case Report. Teke, Hava Üsküdar; Başak, Mustafa; Teke, Deniz; Kanbay, Mehmet // Turkish Journal of Hematology;Mar2014, Vol. 31 Issue 1, p84 

    To follow the progression of multiple myeloma (MM) disease, serum lactate dehydrogenase (LDH) levels are as useful markers as beta-2 microglobulin and monoclonal immunoglobulin. With this study, we have presented a case of a patient with a multiple myeloma which was fulminant course, whose LDH...

  • Multiple Myeloma: An Update. Al-Farsi, Khalil // Oman Medical Journal;Jan2013, Vol. 28 Issue 1, p3 

    Multiple myeloma is a rare, largely incurable malignant disease of plasma cells. Patients usually present with hypercalcemia, renal insufficiency, anemia and/or lytic bony lesions along with a monoclonal protein in the serum and/or urine in addition to an increase in the number of clonal plasma...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics